HAE analyst estimates
Haemonetics (HAE) analyst ratings, the average price target and its range, and every firm's latest call.
HAE analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Oct 9, 2026 | Barrington | Haemonetics price target raised to $140 from $118 at Barrington | $140.00 |
| Oct 9, 2026 | Mizuho Securities | Haemonetics price target raised to $140 from $95 at Mizuho | $140.00 |
| Oct 8, 2026 | BTIG | Haemonetics price target raised to $130 from $110 at BTIG | $130.00 |
| Sep 3, 2026 | Raymond James | Haemonetics price target raised to $125 from $105 at Raymond James | $125.00 |
| Aug 21, 2026 | Robert W. Baird | Haemonetics price target raised to $119 from $96 at Baird | $119.00 |
| Aug 19, 2026 | Barrington | Haemonetics price target raised to $118 from $95 at Barrington | $118.00 |
| Aug 7, 2026 | Barrington | Haemonetics price target raised to $95 from $89 at Barrington | $95.00 |
| Aug 7, 2026 | Robert W. Baird | Haemonetics price target raised to $96 from $88 at Baird | $96.00 |
| Aug 7, 2026 | Raymond James | Haemonetics price target raised to $105 from $90 at Raymond James | $105.00 |
| Aug 6, 2026 | BTIG | Haemonetics (HAE) PT Raised to $96 at BTIG | $96.00 |
| Jun 15, 2026 | Mizuho Securities | Haemonetics (HAE) PT Raised to $85 at Mizuho | $85.00 |
| May 12, 2026 | Barrington | Haemonetics price target lowered to $89 from $94 at Barrington | $89.00 |
| May 8, 2026 | Robert W. Baird | Haemonetics price target lowered to $67 from $72 at Baird | $67.00 |
| Apr 13, 2026 | Mizuho Securities | Haemonetics price target lowered to $70 from $80 at Mizuho | $70.00 |
| Feb 6, 2026 | Robert W. Baird | Haemonetics price target lowered to $81 from $99 at Baird | $81.00 |
- 9 firms rate HAE: 7 buy, 2 hold, 0 sell.
- The average price target is $130.80 from 5 analysts, from $119.00 to $140.00.
Updated 2026-11-02 17:52 UTC